New hope for patients whose aggressive lung cancer fought off chemo

This study is testing an oral medication called Abemaciclib for people with certain aggressive lung cancers that have either not responded to standard chemotherapy or have come back after treatment. The goal is to see if the drug can shrink tumors and control the cancer's growth by targeting specific proteins that drive cancer cell division. It is for a small group of patients whose cancer has a specific genetic feature and has progressed despite prior therapy.